[
    [
        {
            "time": "",
            "original_text": "甘李药业今日大宗交易成交50万股，成交价69.03元折价12.8%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "大宗交易",
                    "成交50万股",
                    "成交价69.03元",
                    "折价12.8%"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "甘李药业今日大宗交易成交50万股，成交价69.03元折价12.8%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "甘李药业现10笔大宗交易，共成交3,451.50万元",
            "features": {
                "keywords": [
                    "甘李药业",
                    "大宗交易",
                    "10笔",
                    "成交3,451.50万元"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "甘李药业现10笔大宗交易，共成交3,451.50万元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "甘李药业（603087.SH）：GZR18中国I期临床试验完成首例受试者入组",
            "features": {
                "keywords": [
                    "甘李药业",
                    "GZR18",
                    "中国I期临床试验",
                    "首例受试者入组"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "甘李药业（603087.SH）：GZR18中国I期临床试验完成首例受试者入组",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]